These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
154 related articles for article (PubMed ID: 36576713)
1. Identification and Validation a Necroptosis-Related Prognostic Signature in Cervical Cancer. Yang Z; Li J; Tang Y; Zou L Reprod Sci; 2023 Jun; 30(6):2003-2015. PubMed ID: 36576713 [TBL] [Abstract][Full Text] [Related]
2. Identification of a necroptosis-related prognostic gene signature associated with tumor immune microenvironment in cervical carcinoma and experimental verification. Sun K; Huang C; Li JZ; Luo ZX World J Surg Oncol; 2022 Oct; 20(1):342. PubMed ID: 36253777 [TBL] [Abstract][Full Text] [Related]
3. Construction and validation of a prognostic signature based on necroptosis-related genes in hepatocellular carcinoma. Peng YL; Wang LX; Li MY; Liu LP; Li RS PLoS One; 2023; 18(2):e0279744. PubMed ID: 36795724 [TBL] [Abstract][Full Text] [Related]
4. Identification and validation of necroptosis-related prognostic gene signature and tumor immune microenvironment infiltration characterization in esophageal carcinoma. Sun K; Hong JJ; Chen DM; Luo ZX; Li JZ BMC Gastroenterol; 2022 Jul; 22(1):344. PubMed ID: 35840882 [TBL] [Abstract][Full Text] [Related]
5. Development and Validation of a Prognostic Model for Esophageal Adenocarcinoma Based on Necroptosis-Related Genes. Zhang S; Liu S; Lin Z; Zhang J; Lin Z; Fang H; Hu Z Genes (Basel); 2022 Nov; 13(12):. PubMed ID: 36553511 [TBL] [Abstract][Full Text] [Related]
6. Identification of a necroptosis-related gene signature for making clinical predictions of the survival of patients with lung adenocarcinoma. Zhou X; Zhao M; Fan Y; Xu Y PeerJ; 2024; 12():e16616. PubMed ID: 38213773 [TBL] [Abstract][Full Text] [Related]
7. Exploration and validation of a novel signature of seven necroptosis-related genes to improve the clinical outcome of hepatocellular carcinoma. Tao Q; Lang Z; Li Y; Gao Y; Lin L; Yu Z; Zheng J; Yu S BMC Cancer; 2023 Oct; 23(1):1029. PubMed ID: 37875823 [TBL] [Abstract][Full Text] [Related]
8. Development of a necroptosis-related gene signature and the immune landscape in ovarian cancer. Nie S; Ni N; Chen N; Gong M; Feng E; Liu J; Liu Q J Ovarian Res; 2023 Apr; 16(1):82. PubMed ID: 37095524 [TBL] [Abstract][Full Text] [Related]
9. Comprehensive Profiling Reveals Prognostic and Immunogenic Characteristics of Necroptosis in Soft Tissue Sarcomas. Qi L; Xu R; Ren X; Zhang W; Yang Z; Tu C; Li Z Front Immunol; 2022; 13():877815. PubMed ID: 35663937 [TBL] [Abstract][Full Text] [Related]
10. Construction of a novel signature and prediction of the immune landscape in gastric cancer based on necroptosis-related genes. Li Z; Yang W; Liu D; Ye W; Du G; Li X Sci Rep; 2022 Aug; 12(1):13290. PubMed ID: 35918354 [TBL] [Abstract][Full Text] [Related]
11. Identification of a necroptosis-related gene signature as a novel prognostic biomarker of cholangiocarcinoma. Xu L; Gao X; Xing J; Guo Z Front Immunol; 2023; 14():1118816. PubMed ID: 36936916 [TBL] [Abstract][Full Text] [Related]
12. A Novel Prognostic Predictor of Immune Microenvironment and Therapeutic Response in Kidney Renal Clear Cell Carcinoma based on Necroptosis-related Gene Signature. Chen W; Lin W; Wu L; Xu A; Liu C; Huang P Int J Med Sci; 2022; 19(2):377-392. PubMed ID: 35165523 [No Abstract] [Full Text] [Related]
13. Identification and Validation of Prognostic Model for Pancreatic Ductal Adenocarcinoma Based on Necroptosis-Related Genes. Xie H; Xu J; Xie Z; Xie N; Lu J; Yu L; Li B; Cheng L Front Genet; 2022; 13():919638. PubMed ID: 35783277 [No Abstract] [Full Text] [Related]
14. An Efficient Signature Based on Necroptosis-Related Genes for Prognosis of Patients With Pancreatic Cancer. Shi H; Peng Q; Zhou X; He Y; Sun S Front Genet; 2022; 13():848747. PubMed ID: 35419022 [TBL] [Abstract][Full Text] [Related]
15. Identification of a Necroptosis-Related Prognostic Signature and Associated Regulatory Axis in Liver Hepatocellular Carcinoma. He A; Huang Z; Wang J; Lu H; Zhang R; Wu L; Feng Q Dis Markers; 2022; 2022():3968303. PubMed ID: 35855852 [TBL] [Abstract][Full Text] [Related]
16. Integrated analysis of necroptosis-related genes for evaluating immune infiltration and colon cancer prognosis. Yang W; Lu S; Peng L; Zhang Z; Zhang Y; Guo D; Ma F; Hua Y; Chen X Front Immunol; 2022; 13():1085038. PubMed ID: 36618366 [TBL] [Abstract][Full Text] [Related]
17. A comprehensive pan-cancer analysis of necroptosis molecules in four gynecologic cancers. Zheng J; Cai X; Zhang Y; Wang H; Liu L; Tang F; Liu L; Sun Y BMC Cancer; 2022 Nov; 22(1):1160. PubMed ID: 36357839 [TBL] [Abstract][Full Text] [Related]
18. Identification and Assessment of Necroptosis-Related Genes in Clinical Prognosis and Immune Cells in Diffuse Large B-Cell Lymphoma. Zhang Q; Zhu Z; Guan J; Zheng C Front Oncol; 2022; 12():904614. PubMed ID: 35814424 [TBL] [Abstract][Full Text] [Related]
19. Construction and validation model of necroptosis-related gene signature associates with immunity for osteosarcoma patients. Hua L; Lei P; Hu Y Sci Rep; 2022 Sep; 12(1):15893. PubMed ID: 36151259 [TBL] [Abstract][Full Text] [Related]
20. Immune infiltration and a necroptosis-related gene signature for predicting the prognosis of patients with cervical cancer. Xing X; Tian Y; Jin X Front Genet; 2022; 13():1061107. PubMed ID: 36685937 [No Abstract] [Full Text] [Related] [Next] [New Search]